全球胶囊内窥镜市场-预测 (2022-2027)

预计2020年全球胶囊内窥镜市场规模为883,244,000美元，预测期内復合年增长率为6.04%，到2027年达到1,331,795,000美元。预计。 推动市场增长的关键因素包括支持性政府举措、对更快、更准确诊断的需求增加、肠道疾病和消化系统疾病发病率增加、老年人口增加等。 另一方面，胶囊内镜的风险和并发症，以及熟练医生的短缺成为问题。

本报告研究了全球胶囊内窥镜市场，包括市场概况、市场规模和预测、趋势、驱动因素和製约因素，按组件、内窥镜类型、产品和应用分类。我们按个人、最终用户提供分析、地理区域、竞争格局等。

内容

第一章介绍

• 市场概览
• COVID-19 情景
• 市场定义
• 市场细分

第二章研究方法论

• 调查数据
• 先决条件

第 3 章执行摘要

• 调查要点

第四章市场动态

• 市场驱动力
• 市场製约因素
• 波特的五力分析
  • 最终用户的议价能力
  • 买家的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 行业内竞争公司之间的敌对关係
• 行业价值链分析

第 5 章胶囊内窥镜市场：按组件分类

• 简介
• 胶囊内窥镜检查
• 胶囊内窥镜数据记录仪
• 胶囊内镜工作站

第 6 章胶囊内窥镜市场：按内窥镜类型分类

• 简介
• 胶囊膀胱镜
• 胶囊神经内窥镜

第 7 章胶囊内窥镜市场：按产品分类

• 简介
• 小肠
• 食道
• 大肠

第 8 章胶囊内窥镜市场：按应用

• 简介
• OGIB
• 克罗恩病
• 肠道疾病
• 其他

第 9 章胶囊内窥镜市场：按最终用户分类

• 简介
• 医院
• 医务室
• 其他

第 10 章胶囊内窥镜市场：按地区

• 简介
• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 欧洲
  • 英国
  • 德国
  • 法国
  • 意大利
  • 西班牙
  • 其他
• 中东和非洲
  • 沙特阿拉伯
  • 阿拉伯联合酋长国
  • 以色列
  • 其他
• 亚太地区
  • 中国
  • 日本
  • 韩国
  • 印度
  • 印度尼西亚
  • 泰国
  • 台湾
  • 其他

第11章竞争格局与分析

• 主要公司和战略分析
• 新兴公司和市场盈利能力
• 合併、收购、协议和合作
• 供应商竞争力矩阵

第12章公司简介

• JInshan Science & Technology
• IntroMedic Co. Ltd.
• Olympus America Inc.
• CapsoVision Inc.
• Medtronic Plc.
• FujiFilm Corporation
• RF Co. Ltd.
• Boston Scientific Corporation
• Steris Corporation

The capsule endoscopy market was valued at US$883.244 million in 2020 and is expected to grow at a CAGR of 6.04% over the forecast period to reach a market size of US$1,331.795 million in 2027.

A capsule endoscopy camera is like a vitamin-size capsule that is swallowed by people. The procedure of Capsule Endoscopy is done with the use of a tiny wireless camera that takes images of the digestive tract. The capsule contains video chips, a light bulb, a battery, and a radio transmitter. It takes thousands of images as it travels through our digestive tract; and sends them through the transmitter. These images are used by the doctor to see areas that cannot be reached easily with traditional endoscopy procedures. The main use of the capsule is to diagnose gastrointestinal complications, inflammatory bowel diseases, celiac diseases, polyps screening, oesophagus examination, and abnormal tissue growth where the traditional endoscopy is ineffective and helps in at-time and faster recovery. The growth of the capsule endoscopy market is substantiated by supportive government initiatives, increasing demand for faster and more accurate diagnostics, growing incidences of intestinal disorders and gastrointestinal diseases, and the increasing geriatric population. However, the risks and complications of capsule endoscopy and the lack of skilled physicians remain major challenges.

Drivers

The rising geriatric population base is projected to provide the capsule endoscopy market with a strong platform for growth over the analyzed period. Aging significantly increases the risk of gastrointestinal disorders like inflammatory bowel disease, Crohn's disease, colorectal cancer, and appendicitis, to name a few. Further, the growing prevalence of cancer in older as well as younger adults in recent times and the increasing adoption of screening tests, including capsule endoscopy for detection is likely to propel market growth. According to the statistics provided by the American Cancer Society, it is projected that about 1.9 million cancer cases would be reported in the US by the end of 2022. Such an increasing prevalence is thus expected to catalyze the growth of the market.

Further, the growing adoption of minimally invasive surgical interventions has accelerated the utilization of capsule endoscopic systems and wireless capsules, majorly for the detection or diagnosis of gastrointestinal issues such as OGIB (obscure gastrointestinal tract bleeding), Crohn's disease, cancer, and small intestine tumor. Capsule endoscopy provides efficient and rapid results concerning screening of such conditions, thereby boosting the adoption of this method and leading to market growth.

Adding to that, strategic alliances among market players, such as mergers, acquisitions, and partnerships, along with growing R&D in the area of capsule-based endoscopic technologies are some of the factors that are further expected to drive the growth of the market. for instance, in 2020, Medtronic announced a partnership with Amazon for the home delivery of its capsule endoscope, PillCam Genius. Through this partnership, it aimed at increasing its penetration at a global scale and enhancing patient comfort and satisfaction.

Application Insights

Based on application, the OGIB segment is expected to hold dominant shares in the market, due to the numerous advantages provided by capsule endoscopy in the diagnosis and detection of OGIB. Additionally, benefits like real-time visualization, image capturing, and analysis of the entire small intestine, along with reliable and precise results attribute to the increase in the adoption of capsule endoscopes for OGIB. Further, the shift in trend towards the adoption of capsule-based endoscopy screening for OGIB as compared to the other conventional methods, such as double-balloon enteroscopy, is further expected to aid in the growth of the segment.

Moreover, the Crohn's disease segment is projected to grow at a substantial rate during the analyzed period due to the increasing utilization of capsule endoscopes for the detection of Crohn's disease. It is considered one of the most common types of Inflammatory Bowel Disease (IBD) and the rising prevalence of IBD, along with Crohn's disease is likely to augment market growth during the forecasted period. Canada has one of the highest incidence rates of IBD, including Crohn's disease and ulcerative colitis. For instance, according to 2021 statistics provided by Crohn's and Colitis Canada, around 260,000 people in the country were found to be living with IBD which is a substantially high number. In addition, the IBD prevalence rate is anticipated to increase by 50% by the year 2030, with around 400,000 Canadians getting diagnosed with IBD, according to a study by Crohn's and Colitis Canada in 2018.

COVID-19 insights

The outbreak of the COVID-19 pandemic had a mixed impact on the capsule endoscopy market. The delay, cancellation, and reduction in the number of elective surgeries performed during the initial phases of the pandemic significantly impacted the market. Further, changing regulations with regard to surgical interventions and endoscopic screening procedures, and imbalance in the supply chain were some of the key factors that hindered the growth of the market for capsule endoscopy during the pandemic.

Furthermore, capsule endoscopy training for medical professionals was also impacted severely. Several institutions opted for e-learning modules for training. However, the advantages provided by capsule endoscopy boosted the growth of the market post the initial phases of the pandemic. For instance, according to a 2021 cohort study of 146 patients (out of which 74 were COVID-19 positives) published by JAMA Network, active bleeding was identified more frequently using video capsule endoscopy as the first strategy, at about 59.5%, as compared to the traditional detection process. Hence, such instances provided growth to the market and are expected to accelerate the growth even further now that the condition has gotten better.

Market Segmentation:

By Component

Capsule Endoscopy

Capsule Endoscopy Data Recorder

Capsule Endoscopy Workstations

By Endoscope Type

Cystoscopies

Neuro-Endoscopes

By Product

Small Bowel Capsule

Esophageal Capsule

Colon Capsule

By Application

Obscure Gastrointestinal Bleeding

Crohn's Disease

Intestine Disease

Others

By End-User

Hospitals

Clinics

Others

By Geography

North America

USA

Canada

Mexico

South America

Brazil

Argentina

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Others

Middle East and Africa

Saudi Arabia

UAE

Israel

Others

Asia Pacific

China

Japan

South Korea

India

Indonesia

Thailand

Taiwan

Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Covid-19 Scenario
• 1.3. Market Definition
• 1.4. Market Segmentation

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Assumptions

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of End-Users
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. CAPSULE ENDOSCOPY MARKET BY COMPONENT

• 5.1. Introduction
• 5.2. Capsule Endoscopy
• 5.3. Capsule Endoscopy Data Recorder
• 5.4. Capsule Endoscopy Workstations

6. CAPSULE ENDOSCOPY MARKET BY ENDOSCOPE TYPE

• 6.1. Introduction
• 6.2. Cystoscopies
• 6.3. Neuro-Endoscopes

7. CAPSULE ENDOSCOPY MARKET By Product

• 7.1. Introduction
• 7.2. Small Bowel Capsule
• 7.3. Esophageal Capsule
• 7.4. Colon Capsule

8. CAPSULE ENDOSCOPY MARKET By Application

• 8.1. Introduction
• 8.2. Obscure Gastrointestinal Bleeding
• 8.3. Crohn's Disease
• 8.4. Intestine Disease
• 8.5. Others

9. CAPSULE ENDOSCOPY MARKET BY END-USER

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Clinics
• 9.4. Others

10. CAPSULE ENDOSCOPY MARKET BY GEOGRAPHY

• 10.1. Introduction
• 10.2. North America
  • 10.2.1. United States
  • 10.2.2. Canada
  • 10.2.3. Mexico
• 10.3. South America
  • 10.3.1. Brazil
  • 10.3.2. Argentina
  • 10.3.3. Others
• 10.4. Europe
  • 10.4.1. UK
  • 10.4.2. Germany
  • 10.4.3. France
  • 10.4.4. Italy
  • 10.4.5. Spain
  • 10.4.6. Others
• 10.5. Middle East and Africa (MEA)
  • 10.5.1. Saudi Arabia
  • 10.5.2. UAE
  • 10.5.3. Israel
  • 10.5.4. Others
• 10.6. Asia Pacific
  • 10.6.1. China
  • 10.6.2. Japan
  • 10.6.3. South Korea
  • 10.6.4. India
  • 10.6.5. Indonesia
  • 10.6.6. Thailand
  • 10.6.7. Taiwan
  • 10.6.8. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 11.1. Major Players and Strategy Analysis
• 11.2. Emerging Players and Market Lucrativeness
• 11.3. Mergers, Acquisitions, Agreements, and Collaborations
• 11.4. Vendor Competitiveness Matrix

12. COMPANY PROFILES

• 12.1. JInshan Science & Technology
• 12.2. IntroMedic Co. Ltd.
• 12.3. Olympus America Inc.
• 12.4. CapsoVision Inc.
• 12.5. Medtronic Plc.
• 12.6. FujiFilm Corporation
• 12.7. RF Co. Ltd.
• 12.8. Boston Scientific Corporation
• 12.9. Steris Corporation